Author(s): Tanpure R. R., Kolhe M. H., Shinde G. S., Bhor R. J.

Email(s): rushikeshprcop@gmail.com

DOI: 10.52711/0974-360X.2024.00377   

Address: Tanpure R. R.1*, Kolhe M. H.1, Shinde G. S.2, Bhor R. J.1
1Department of Pharmaceutical Quality Assurance, Pravara Rural College of Pharmacy, Loni, Pravaranagar, Tal - Rahata, Dist. Ahmednagar (MH) - 413736, India.
2Department of Pharmaceutics, Institute of Pharmacy, Loni KD, Tal - Rahata, Dist. Ahmednagar (MH) - 413736, India.
*Corresponding Author

Published In:   Volume - 17,      Issue - 5,     Year - 2024


ABSTRACT:
The main objective of the given study is that to develop and validate stability indicating reverse phase HPLCmethod for the simultaneous estimation of combined Omeprazole and domperidone in solid dosage forms. The method was optimized Shimadzu RP-LC (HPLC) system with a SPD 10A UV detector (BDS C18 column (250×4.6mm I.D Hypersil). methanol and ammonium acetate buffer (60:40). Methanol is used as diluents. The flow rate is 1ml/min and the effluent is monitor at 280nm. Results: The retention time of combined Omeprazole and domperidone was 6.75min. and 9.64min. respectively. The proposed method study was simple, precise,rapid, accurate and. It was economical and suitable for continuous determination of combined Omeprazole and domperidone in pharmaceutical dosage form. For RP-HPLC, separation of components were achieved at a Phenomenex Rp-C18 column. The components detected by UV detection at range of 295nm. Thus, the evaluation method is applicable for regular determination of combined omeprazole and domperidone in pharmaceutical formulations.The drugs were placed to different adverse conditions like acid, base, neutral hydrolysis, oxidation, and photo-degradation. The validation of developed method was successfully applied to the simultaneous evaluation of combined omeprazole and domperidone by Reverse Phase-High Performance Liquid Chromatography. Report by RP-HPLC were good assumed.


Cite this article:
Tanpure R. R., Kolhe M. H., Shinde G. S., Bhor R. J.. A Review on Simultaneous Estimation of combination of Omeprazole and Domperidone in Bulk and Tablet by RP-HPLC Method. Research Journal of Pharmacy and Technology. 2024; 17(5):2409-2. doi: 10.52711/0974-360X.2024.00377

Cite(Electronic):
Tanpure R. R., Kolhe M. H., Shinde G. S., Bhor R. J.. A Review on Simultaneous Estimation of combination of Omeprazole and Domperidone in Bulk and Tablet by RP-HPLC Method. Research Journal of Pharmacy and Technology. 2024; 17(5):2409-2. doi: 10.52711/0974-360X.2024.00377   Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2024-17-5-73


REFERENCES:
1.    Indian Pharmacopoeia. Vol. 1, The Controller of Publications, Delhi, 1996, 532.
2.    The United States Pharmacopoeia, Vol. XXIV, Supplement 7, The U.S. Pharmacopoeia Convention, Inc. Rockville, MD, 2000.
3.    National Center for Biotechnology Information (2021). PubChem Compound Summary for CID3151, Domperidone. Retrieved, at December 15, 2021 From https://pubchem.ncbi.nlm.nih.gov/compound/Domperidone.
4.    Kumar PV. Chandra BC. et al Development and validation of new analytical method for the simultaneous estimation of omeprazole and domperidone in pharmaceutical dosage form by UV spectrophotometer. International Journal of Research in Pharmaceutical Chemistry and Analysis. 2019; 1(2). http://dx.doi.org/10.33974/ijrpca.v1i2.63
5.    Strand DS. Kim D. Peura DA. 25 years of proton pump inhibitors: a comprehensive review. Gut and liver. 2017; 11(1): 27-37.https://doi.org/10.5009/gnl15502
6.    Lewin MJ. Cellular mechanisms and inhibitors of gastric acid secretion. Drugs Today (Barc). 1999; 35(10):743-52.https://doi.org/10.1358/dot.1999.35.10.561693
7.    Sachs G. Wallmark B. The gastric H+, K+-ATPase: the site of action of omeprazole. Scandinavian Journal of Gastroenterology Supplement. 1989; 166:3-11. PMID: 2557669.
8.    Prilosec (omeprazole) Delayed-Release Capsules and Prilosec (omeprazole magnesium) For Delayed-Release Oral Suspension Initial U.S. Approval: 1989
9.    https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019810s096lbl.pdf
10.    Faassen F. Vogel G. Spanings H. Vromans H. Caco-2 permeability, P-glycoprotein transport ratios and brain penetration of heterocyclic drugs. International Journal of Pharmaceutics. 2003; 263(1-2): 113-122. https://doi.org/10.1016/S0378-5173(03)00372-7
11.    Guideline ICH. Validation of analytical procedures: text and methodology. Q2, (R1). 2005 Nov; 1 (20):05.
12.    Guideline IH. Validation of analytical procedures: text and methodology. Q2 (R1). 2005 Nov; 1(20):05.
13.    Kakad SB. Kolhe MH. Dukre TP. A Review on Pharmaceutical Validation. International Journal of Pharmaceutical Quality Assurance. 2020; 11(3): 338-342. DOI: 10.25258/ijpqa.11.3.6
14.    Kamala GR. Vadrevu S. Haripriya M. Method Development and Validation for Simultaneous Estimation of Omeprazole and Domperidone by RP-HPLC. Asian Journal of Pharmaceutical Analysis. 2015; 5(4): 195-205.https://www.doi.org/10.5958/2231-5675.2015.00031.9
15.    Krishnaiah V. RamiReddy YV. Development and Validation of HPLC Method for Simultaneous Determination of Omeprazole and Domperidone, Der Pharma Chemica. 2012; 4(1): 455-459.
16.    Schinkel AH.Wagenaar E. Mol CA. Deemter LV. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. The Journal of Clinical Investigation. 1996; 97(11): 2517-2524. https://doi.org/10.1172/JCI118699
17.    Sivasubramanian L. Anilkumar A. Simultaneous HPLC Estimation of Omeprazole and Domperidone from Tablets. Indian Journal of Pharmaceutical Sciences. 2007; 69(5): 674-676. DOI: 10.4103/0250-474X.38474


Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available